Proyeksi Harga BBP & Analisis ETF - Dividen·Biaya Pengelolaan·Komposisi Saham·NAV·RSI·MACD | Saham AS Hari Ini
10 Nov pukul 4:00 PM ET (Korea 11/11 06:00)Pola grafik yang digambar AI hanya sebagai acuan.
Tabel metrik lengkap
| Category | US Equities - Industry Sector | Expense | 0.34% | Return% 1Y | 40.88% | Total Holdings | 68 | Perf Week | 0.22% | Volume | 14,913 |
| Asset Type | Equities (Stocks) | AUM | $136M | Return% 3Y | 29.94% | NAV | $104.38 | Perf Month | 0.12% | Avg Volume | 0.01M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 14.45% | 52W High | -5.72% | Perf Quarter | 1.8% | Rel Volume | 1.19 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 13.59% | 52W Low | 40.26% | Perf Half Y | 17.39% | Prev Close | $104.53 |
| IPO | 2014/12/17 | Flows% 1M | 3.99% | Return% SI | 12.52% | RSI (14) | 50.36 | Perf YTD | 29.83% | Price | $103.75 |
| Beta | 0.58 | Flows% 3M | 23.86% | Flows% YTD | 109.71% | Flows% 1Y | 156.51% | Perf Year | 38.31% | Volatility(W/M) | 2.98% 2.41% |
| SMA20 | 0.2% | SMA50 | -0.35% | SMA200 | 11.31% | ATR | 2.57 | ||||
Virtus Biotech ETFBBP | NYSE | Sektor kesehatan Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
10 terbesar mencakup 20% dari dana
Tersebar merata di banyak kepemilikan.
CRNX CRINETICS PHARMACEUTICALS INC 3.34% 2 
KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC 1.97% 3 
VSTM VERASTEM INC 1.95% 4 
PGEN PRECIGEN INC 1.94% 5 
OMER OMEROS CORP 1.87% 6 
NUVB NUVATION BIO INC 1.77% 7 
REGN REGENERON PHARMACEUTICALS 1.72% 8 
PTGX PROTAGONIST THERAPEUTICS INC 1.71% 9 
ACAD ACADIA PHARMACEUTICALS INC 1.69% 10 
ONC BEONE MEDICINES LTD 1.65% Sektor dengan bobot terbesar lebih dulu.
Dalam 1 tahun terakhir, cukup tinggi
6% di bawah harga tertinggi 1 tahun.
Diperdagangkan kurang lebih seperti biasanya. Itu 119% dari volume rata-ratanya.
Menahan lama akan menguntungkan
Jika dibeli 5 tahun lalu, imbal hasil Anda sekarang +104.0%. Dalam periode yang sama S&P 500 mencatat +62%.
Ketuk untuk melihat angka
Harganya bergerak besar
Pada titik terburuk (Februari 2021) turun 44% dan butuh 659 hari untuk pulih.
Ketuk untuk melihat angka
Tidak ada dividen
Belum ada laba untuk dibagikan.
Uang terus masuk
Selama setahun terakhir, uang baru setara 156.5% aset masuk.
Ketuk untuk melihat angka
CURE Direxion Daily Healthcare Bull 3X ETF 211M 
RXL ProShares Ultra Health Care 2X Shares 117M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 40M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 4M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
XBI State Street SPDR S&P Biotech ETF 0.35% 
IYH iShares U.S. Healthcare ETF 0.37% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
